Clinical Trial Update: Augmenting Language Therapy for Aphasia: Levodopa [Phase 2, Phase 3]

View source ↗

Summary

This document reports completion and results posting for Phase 2 and Phase 3 trials evaluating levodopa as an adjunct to language therapy for nonfluent aphasia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonfluent Aphasia
• Stroke

Drugs mentioned

• levodopa (levodopa)

Snippet

Sponsor: Shirley Ryan AbilityLab | Conditions: Nonfluent Aphasia, Stroke | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-11-28